Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioadaptives Inc (OP: BDPT )

0.0044 -0.0001 (-2.22%)
Streaming Delayed Price Updated: 1:05 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 89,502
Open 0.0049
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0045
Today's Range 0.0044 - 0.0049
52wk Range 0.0018 - 0.0485
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioAdaptives, Inc. Brings Top Revolutionary Formulas Together in Wellness Introductory Offer
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
BioAdaptives, Inc. Seeks to Increase Market Share in $1.9 Billion Global Pet Supplements Market With Canine All-In-One Premium Nutraceutical
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Derivatives
Exposures Derivatives

Performance

YTD
-56.00%
-56.00%
1 Month
-20.00%
-20.00%
3 Month
-20.00%
-20.00%
6 Month
-56.00%
-56.00%
1 Year
-87.02%
-87.02%

More News

Read More
BioAdaptives, Inc. Reveals Corporate Strategy for a Strengthened Market Presence, Through Empowerment of Seniors, as Nutraceutical Market Surpasses $454 Billion USD
Via NewMediaWire
BioAdaptives Sponsors COVID-19 Long Hauler Survey
Via NewMediaWire
Exposures COVID-19
BioAdaptives Expands Gadolinium Deposition Disease Survey
Via NewMediaWire
BioAdaptives Announces Initial Investigation Results Pluripain Improves Symptoms of Gadolinium Deposition Disease
Via NewMediaWire
BioAdaptives Acquires Oxygenated Water Technology Patent and Forms Subsidiary, MORO2, Inc., to Create New Products
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
BioAdaptives to Investigate Use of Lung Cleanser for Long-Term Smokers
Via NewMediaWire
BioAdaptives Signs Letter of Intent to Acquire Oxygenated Water Technology Patent
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
BioAdaptives' LungFlute Marketing Agreement and New Product
Via NewMediaWire
BioAdaptives Collaboration with Stanford Professor
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
BioAdaptives -- Livestock Impact Division Announcement
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
BioAdaptives Inks Agreement With UK-Based Internet Marketer
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
BioAdaptives Management Additions
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
BioAdaptives Commences Social Media Roll-Out
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.